No Detail Found!

Hypoglycemia with Beta-Blocker in Patients with Type II Diabetes

Author(s)
Rahmat Wali Department of Medicine, Lady Reading Hospital, Peshawar, Pakistan
Noor Mohammad Department of Nephrology, Lady Reading Hospital, Peshawar, Pakistan,
Naseem Ur Rehman Department of Medicine, Lady Reading Hospital, Peshawar, Pakistan
Tahir Ullah Khan Oral & Maxillofacial Surgery, Lady Reading Hospital, Peshawar, Pakistan,
Muhammad Waqas Department of General Surgery, Lady Reading Hospital,Peshawar,Pakistan
Umair Khan Kabir Medical College Peshawar,,Pakistan
Abstract
Objective: To ascertain the frequency of hypoglycemia in diabetic patients using beta blockers. Study Design: A descriptive cross-sectional study. Place and Duration of Study: The study was conducted in the Department of Nephrology and Medicine, Lady Reading Hospital Peshawar, Pakistan, from 10th October 2021 to 10th April 2022. Materials and Methods: The total number of diabetic patients with hypoglycemia was 196, who were included in this study. The patients' medical record was assessed, and the use of beta-blocker was noted and recorded. Results: This study included those patients whose ages ranged from 30 to 70 years, with a mean age of 51.964±6.38 years. The average duration of diabetes was 7.989±2.74 years, and an average weight of 87.178 kg. Male patients were 71.9%, and females were 28.1%, 43.9% of diabetic patients who had hypoglycemia used beta blockers. Conclusion: According to this study, diabetic people who take oral beta-blockers have a higher risk of developing hypoglycemia. This research shows that Beta Blocker use causes increased chances of hypoglycemia in people with diabetes.
Publication Details
Page(s) 253-257
Published Journal: Life and Science, Volume: 4, Issue: 3, Year: 2023

Request the full text from PASTIC

Keywords
Beta blocker, Type II Diabetes, Hypoglycemia
0

Citations

0

Downloads

66

Views